(9) Additionally, Pal-GHK has been suggested to have the potential to reduce the release of iron from ferritin, which catalyzes lipid peroxidation
On the other hand, inhibition of GSH synthesis with BSO, independently of the cysteine pool, has been repeatedly described to induce ferroptosis (42)
Klinischer Status: GHK-Cu ist ein endogenes kupferbindendes Peptid , das sowohl in Tier- als auch in Humanforschungsmodellen fr Wundheilung, Hautregeneration und Anti-Aging-Anwendungen untersucht wird
In the SURMOUNT-1 phase-3 trial, tirzepatide produced dose-dependent weight loss reaching about ~21% of total body weight at the 15 mg dose, substantially more than placebo, with gastrointestinal symptoms the most common adverse events [6] [7]
Satellite cells and the muscle stem cell niche